General Info
| Host: | Mouse |
| Applications: | WB/IF |
| Reactivity: | Human/Mouse/Rat/Cow/Dog/Goat/Pig/Rabbit/Sheep |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: | Mouse monoclonal antibody anti-Peroxisome proliferator-activated receptor gamma (C-Term) is suitable for use in Western Blot and Immunofluorescence research applications. |
| Clonality: | Monoclonal |
| Conjugation: | Unconjugated |
| Formulation: | Liquid in 0.1M Tris-Glycine (pH7.4, 150 mM NaCl) , 0.2% Sodium Azide and 50% Glycerol. |
| Purification: | Affinity purification |
| Concentration: | 1 mg/mL |
| Dilution Range: | WB 1:1000-1:2000IF 1:100-1:500 |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Information
| Gene Symbol: | PPARG |
| Gene ID: | 5468 |
| Uniprot ID: | PPARG_HUMAN |
| Immunogen Region: | C-Term |
| Specificity: | PPAR-Gamma Monoclonal Antibody detects endogenous levels of PPAR-Gamma protein. |
| Immunogen: | Purified recombinant human PPAR-Gamma (C-terminus) protein fragments expressed in E.coli. |
Description
| Post Translational Modifications | O-GlcNAcylation at Thr-84 reduces transcriptional activity in adipocytes. Phosphorylated in basal conditions and dephosphorylated when treated with the ligand. May be dephosphorylated by PPP5C. The phosphorylated form may be inactive and dephosphorylation at Ser-112 induces adipogenic activity. Ubiquitinated by E3 ubiquitin-protein ligase complex containing FBXO9.leading to proteasomal degradation. |
| Function | Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated pro-inflammatory responses. Plays a role in the regulation of cardiovascular circadian rhythms by regulating the transcription of BMAL1 in the blood vessels. (Microbial infection) Upon treatment with M.tuberculosis or its lipoprotein LpqH, phosphorylation of MAPK p38 and IL-6 production are modulated, probably via this protein. |
| Protein Name | Peroxisome Proliferator-Activated Receptor GammaPpar-GammaNuclear Receptor Subfamily 1 Group C Member 3 |
| Database Links | Reactome: R-HSA-1989781Reactome: R-HSA-381340Reactome: R-HSA-383280Reactome: R-HSA-4090294Reactome: R-HSA-8943724Reactome: R-HSA-9022707 |
| Cellular Localisation | NucleusCytoplasmRedistributed From The Nucleus To The Cytosol Through A Map2k1/Mek1-Dependent MannerNoct Enhances Its Nuclear Translocation |
| Alternative Antibody Names | Anti-Peroxisome Proliferator-Activated Receptor Gamma antibodyAnti-Ppar-Gamma antibodyAnti-Nuclear Receptor Subfamily 1 Group C Member 3 antibodyAnti-PPARG antibodyAnti-NR1C3 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance